Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 12 Neoplasms 7 cyclopia sequence 6 Polycystic Ovary Syndrome 4 Fatigue 4 Obesity 3 Multiple Myeloma 3 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pain 2 Neoplasms, Plasma Cell 2 Hematologic Diseases 2 Head and Neck Neoplasms 2 Depression 2 Weight Loss 1 Warts 1 Vomiting 1 Vitamin D Deficiency 1 Urinary Bladder Neoplasms 1 Testicular Neoplasms 1 Small Cell Lung Carcinoma 1 Sleepiness 1 Sezary Syndrome 1 Prostatic Intraepithelial Neoplasia 1 Primary Myelofibrosis 1 Precancerous Conditions 1 Peripheral Nervous System Diseases 1 Periampullary Carcinoma Nos 1

Interventions

Morphine 11 Oxycodone 8 Fentanyl 6 nabiximols 5 Methadone 4 Hydromorphone 4 Acetaminophen 3 Transcutaneous Electric Nerve Stimulation 2 Tapentadol 2 Naloxone 2 Lidocaine 2 Buprenorphine 2 Acupuncture Therapy 2 tanezumab 1 resiniferatoxin 1 oxycodone naloxone combination 1 fulranumab 1 cannabichromene 1 alvimopan 1 Water 1 Ultracet 1 Transcranial Direct Current Stimulation 1 Tramadol 1 Therapeutic Touch 1 Telemedicine 1 Tablets 1 Surveys and Questionnaires 1 Sugars 1 Radiotherapy, Intensity-Modulated 1 Radiosurgery 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Cancer Pain × Sugars × Clear all

NCT00152854 2016-03-08

Acetaminophen for Cancer Pain

University Health Network, Toronto

Phase 3 Completed

Cancer Pain, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡